TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
47 hedge funds and large institutions have $92.8M invested in TFF Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
21% more funds holding
Funds holding: 39 → 47 (+8)
7% less capital invested
Capital invested by funds: $99.6M → $92.8M (-$6.76M)
50% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $2.25M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$7.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.58M |
| 3 |
CA
Corriente Advisors
Fort Worth,
Texas
|
+$4.48M |
| 4 |
Millennium Management
New York
|
+$1.57M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.15M |
| 2 |
PM
Precept Management
Dallas,
Texas
|
-$1.31M |
| 3 |
Renaissance Technologies
New York
|
-$1.12M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$560K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$268K |
TFFP Hedge Fund Activity: Q4 2020 in Review
47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q4 2020, worth a combined $92.8M — down 6.8% from $99.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new TFFP positions and 4 closed out — a net gain of 8 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $7.7M. The largest seller was Nantahala Capital Management, cutting an estimated $4.15M.
- 47 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q4 2020, up from 39 in Q3 2020.
- Funds reported $92.8M of TFF Pharmaceuticals, Inc. Common Stock stock for Q4 2020, down 6.8% quarter-over-quarter.
- 12 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q4 2020 and 4 closed out, a net change of +8 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q4 2020 was Hudson Bay Capital Management, an estimated $7.7M added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q4 2020 was Nantahala Capital Management, an estimated $4.15M sold.
Based on aggregated 13F filings for Q4 2020.